These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38751194)

  • 1. Hit-to-Lead Optimization of the Natural Product Oridonin as Novel NLRP3 Inflammasome Inhibitors with Potent Anti-Inflammation Activity.
    He C; Liu J; Li J; Wu H; Jiao C; Ze X; Xu S; Zhu Z; Guo W; Xu J; Yao H
    J Med Chem; 2024 Jun; 67(11):9406-9430. PubMed ID: 38751194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oridonin ameliorates noise-induced hearing loss by blocking NLRP3 - NEK7 mediated inflammasome activation.
    Li M; Zhang Y; Qiu S; Zhuang W; Jiang W; Wang C; Zhang S; Zhou Z; Sun T; Ke Z; Guo W; Qiao Y; Shi X
    Int Immunopharmacol; 2021 Jun; 95():107576. PubMed ID: 33770730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
    Zhao N; Li CC; Di B; Xu LL
    J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEK7 mediated assembly and activation of NLRP3 inflammasome downstream of potassium efflux in ventilator-induced lung injury.
    Liu H; Gu C; Liu M; Liu G; Wang Y
    Biochem Pharmacol; 2020 Jul; 177():113998. PubMed ID: 32353421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of oridonin derivatives as novel NLRP3 inflammasome inhibitors for the treatment of acute lung injury.
    Li M; Ma L; Lv J; Zheng Z; Lu W; Yin X; Lin W; Wang P; Cui J; Hu L; Liu J
    Eur J Med Chem; 2024 Nov; 277():116760. PubMed ID: 39197252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effect of artemisinin on uric acid-induced NLRP3 inflammasome activation through blocking interaction between NLRP3 and NEK7.
    Kim SK; Choe JY; Park KY
    Biochem Biophys Res Commun; 2019 Sep; 517(2):338-345. PubMed ID: 31358323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity.
    He H; Jiang H; Chen Y; Ye J; Wang A; Wang C; Liu Q; Liang G; Deng X; Jiang W; Zhou R
    Nat Commun; 2018 Jun; 9(1):2550. PubMed ID: 29959312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages.
    Shi Y; Lv Q; Zheng M; Sun H; Shi F
    Int Immunopharmacol; 2021 Mar; 92():107358. PubMed ID: 33508701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
    Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
    Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis.
    Dai Z; Chen XY; An LY; Li CC; Zhao N; Yang F; You ST; Hou CZ; Li K; Jiang C; You QD; Di B; Xu LL
    J Med Chem; 2021 Jan; 64(1):871-889. PubMed ID: 33332136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction.
    Li Q; Feng H; Wang H; Wang Y; Mou W; Xu G; Zhang P; Li R; Shi W; Wang Z; Fang Z; Ren L; Wang Y; Lin L; Hou X; Dai W; Li Z; Wei Z; Liu T; Wang J; Guo Y; Li P; Zhao X; Zhan X; Xiao X; Bai Z
    EMBO Rep; 2022 Feb; 23(2):e53499. PubMed ID: 34882936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin ameliorates insulin resistance partially through inhibition of inflammatory response in rats subjected to chronic unpredictable mild stress.
    Liang L; Zheng Y; Xie Y; Xiao L; Wang G
    Int Immunopharmacol; 2021 Feb; 91():107298. PubMed ID: 33388733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis.
    Li BY; Li P; Wei LY; Zou J; Wang YH; You QD; Jiang C; Di B; Xu LL
    J Med Chem; 2024 Jun; 67(12):9869-9895. PubMed ID: 38888047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling.
    Lin Y; Luo T; Weng A; Huang X; Yao Y; Fu Z; Li Y; Liu A; Li X; Chen D; Pan H
    Front Immunol; 2020; 11():580593. PubMed ID: 33365024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucocalyxin A alleviates LPS-mediated septic shock and inflammation via inhibiting NLRP3 inflammasome activation.
    Hou X; Xu G; Wang Z; Zhan X; Li H; Li R; Shi W; Wang C; Chen Y; Ai Y; Xiao X; Bai Z
    Int Immunopharmacol; 2020 Apr; 81():106271. PubMed ID: 32062071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of PKR as a Direct Target for the Novel Sulfonamide-Substituted Tetrahydroquinoline Nonselective Inhibitor of the NLRP3 Inflammasome.
    Yang F; Dai Z; Xue MY; Chen XY; Liu J; Wang L; Xu LL; Di B
    J Med Chem; 2024 Jun; 67(12):10168-10189. PubMed ID: 38855903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor.
    Chen Y; He H; Lin B; Chen Y; Deng X; Jiang W; Zhou R
    Cell Mol Immunol; 2021 Jun; 18(6):1425-1436. PubMed ID: 33972740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.
    He Y; Zeng MY; Yang D; Motro B; Núñez G
    Nature; 2016 Feb; 530(7590):354-7. PubMed ID: 26814970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEK7: a potential therapy target for NLRP3-related diseases.
    Liu G; Chen X; Wang Q; Yuan L
    Biosci Trends; 2020 May; 14(2):74-82. PubMed ID: 32295992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases.
    Fang ZE; Wang Y; Bian S; Qin S; Zhao H; Wen J; Liu T; Ren L; Li Q; Shi W; Zhao J; Yang H; Peng R; Wang Q; Bai Z; Xu G
    Phytomedicine; 2024 Jan; 122():155159. PubMed ID: 37931457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.